for use in Japan only.
FEATURES
- 01Co-developed with the National Cancer Center Japan
This medical device was jointly developed with the National Cancer Center Hospital East and is officially approved for clinical use in Japan.
- 02Proven to Improve Surgeon Sensitivity
Studies have demonstrated that using SurVis-Pel improves surgeons’ sensitivity in identifying critical organs.
- 03AI-Powered Analysis of 4 Organs in Pelvic / Lateral Lymph Node Dissection
During laparoscopic or robotic pelvic / lateral lymph node dissection, the AI analyzes and highlights the ureter, obturator nerve, external iliac artery, and external iliac vein in real time.
Ureter highlighted in light greenObturator nerve highlighted in purpleExternal iliac artery highlighted in pinkExternal iliac vein highlighted in sky blue
EVIDENCE
A multicenter study conducted in collaboration with the National Cancer Center Hospital East and other institutions evaluated surgeons' recognition performance with and without AI assistance.
Video-based assessment tasks were created using laparoscopic and robot-assisted pelvic and lateral pelvic lymph node dissection procedures collected from institutions across Japan. A total of 36 surgeons participated in the study. Recognition sensitivity for each anatomical structure was compared between surgeons working independently and surgeons assisted by AI-generated visual highlighting.
The results demonstrated that AI assistance significantly improved both sensitivity and specificity compared with surgeon assessment alone, supporting the role of AI in enhancing intraoperative anatomical recognition.
How to Use
Our software simply connects to existing laparoscopy systems such as da Vinci and Stryker, enabling real-time intraoperative analysis — without requiring any injections, dyes, or other invasive procedures.
